|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-10-27
|
|
pubmed:abstractText |
Metastatic renal cell carcinoma (RCC) is rising in incidence but remains difficult to treat. This clinical trial evaluated the effects of pemetrexed (multitargeted antifolate, ALIMTAR) for the treatment of metastatic RCC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0167-6997
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
353-8
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14578684-Aged,
pubmed-meshheading:14578684-Antineoplastic Agents,
pubmed-meshheading:14578684-Carcinoma, Renal Cell,
pubmed-meshheading:14578684-Dose-Response Relationship, Drug,
pubmed-meshheading:14578684-Drug Administration Schedule,
pubmed-meshheading:14578684-Drug Therapy, Combination,
pubmed-meshheading:14578684-Female,
pubmed-meshheading:14578684-Folic Acid,
pubmed-meshheading:14578684-Glutamates,
pubmed-meshheading:14578684-Guanine,
pubmed-meshheading:14578684-Hematinics,
pubmed-meshheading:14578684-Humans,
pubmed-meshheading:14578684-Infusions, Intravenous,
pubmed-meshheading:14578684-Kidney Neoplasms,
pubmed-meshheading:14578684-Male,
pubmed-meshheading:14578684-Middle Aged,
pubmed-meshheading:14578684-Time Factors,
pubmed-meshheading:14578684-Treatment Outcome,
pubmed-meshheading:14578684-Vitamin B 12
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
A phase II trial of pemetrexed in patients with metastatic renal cancer.
|
|
pubmed:affiliation |
Deutsche Klinik fuer Diagnostik, Wiesbaden, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
